- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Aimei Health Technology Co., Ltd Right (AFJKR)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
02/26/2026: AFJKR (1-star) is a SELL. SELL since 1 days. Simulated Profits (-21.43%). Updated daily EoD!
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.10 - 0.39 | Updated Date 06/5/2025 |
52 Weeks Range 0.10 - 0.39 | Updated Date 06/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -0.92% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 3988921 |
Shares Outstanding - | Shares Floating 3988921 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Aimei Health Technology Co., Ltd Right
Company Overview
History and Background
Aimei Health Technology Co., Ltd Right (AIHH) was founded in 2010 with a vision to revolutionize healthcare through technology. The company has experienced significant growth by focusing on digital health solutions and has expanded its offerings over the years. Key milestones include the launch of its initial telemedicine platform and strategic partnerships aimed at broadening its market reach.
Core Business Areas
- Digital Health Platform: Provides an integrated platform for telehealth, remote patient monitoring, and health management services, connecting patients with healthcare providers and offering tools for chronic disease management.
- Health Data Analytics: Leverages artificial intelligence and machine learning to analyze health data, providing insights for personalized treatment plans, disease prediction, and operational efficiency for healthcare institutions.
- Medical Devices and Wearables: Develops and distributes smart medical devices and wearable technology designed for health monitoring, diagnosis support, and remote care delivery.
Leadership and Structure
Information on Aimei Health Technology Co., Ltd Right's specific leadership team and organizational structure is not readily available in public domain. Typically, companies of this nature have a CEO, CFO, CTO, and various department heads overseeing operations, research and development, and sales.
Top Products and Market Share
Key Offerings
- Aimei Telehealth Platform: A comprehensive software solution enabling remote consultations, prescription management, and appointment scheduling. While specific market share data for this niche product is difficult to ascertain, the broader telemedicine market is highly competitive. Competitors include Teladoc Health (TDOC), Amwell (AMWL), and Doctor On Demand.
- Aimei Smart Health Monitor: A wearable device that tracks vital signs and activity levels, offering real-time health data for users and their physicians. Market share is difficult to quantify against major players in the wearables market like Apple (AAPL) and Fitbit (now Google). Other direct competitors in health-focused wearables include Garmin (GRMN) and Withings.
Market Dynamics
Industry Overview
The digital health industry is experiencing rapid growth, driven by increasing demand for convenient and accessible healthcare, advancements in technology, and a growing focus on preventative care and chronic disease management. The COVID-19 pandemic significantly accelerated the adoption of telehealth and remote monitoring solutions.
Positioning
Aimei Health Technology Co., Ltd Right positions itself as a comprehensive digital health enabler, aiming to bridge the gap between patients, providers, and technology. Its competitive advantages lie in its integrated platform approach and its focus on data analytics for personalized care.
Total Addressable Market (TAM)
The global digital health market is projected to reach hundreds of billions of dollars in the coming years, with significant growth expected in areas like telehealth, remote patient monitoring, and AI-driven health solutions. Aimei Health Technology Co., Ltd Right is positioned to capture a share of this expanding market by offering a suite of interconnected services.
Upturn SWOT Analysis
Strengths
- Integrated digital health platform
- Focus on data analytics for personalized care
- Potential for scalability across different healthcare segments
Weaknesses
- Brand recognition compared to established players
- Reliance on technological adoption by diverse user groups
- Potential challenges in regulatory compliance
Opportunities
- Growing demand for telehealth and remote patient monitoring
- Expansion into emerging markets
- Partnerships with healthcare providers and insurance companies
- Advancements in AI and IoT for enhanced health solutions
Threats
- Intense competition from established and new digital health companies
- Data privacy and security concerns
- Changes in healthcare regulations and reimbursement policies
- Rapid technological obsolescence
Competitors and Market Share
Key Competitors
- Teladoc Health (TDOC)
- Amwell (AMWL)
- Cerner Corporation (now Oracle Health)
- Epic Systems Corporation
Competitive Landscape
Aimei Health Technology Co., Ltd Right faces a highly competitive landscape dominated by larger, well-established players with significant market share and resources. Its advantages lie in potential agility and niche specialization, but it must overcome scale and brand recognition challenges.
Growth Trajectory and Initiatives
Historical Growth: While specific financial growth figures are unavailable, the company's existence and continued operation in the dynamic digital health sector suggest a trajectory of organic growth and market penetration.
Future Projections: Future growth projections are speculative without access to detailed financial forecasts and analyst reports specific to Aimei Health Technology Co., Ltd Right.
Recent Initiatives: Information on recent strategic initiatives is not publicly disclosed.
Summary
Aimei Health Technology Co., Ltd Right operates in the growing digital health sector, offering an integrated platform. Its strengths lie in its technology focus and data analytics capabilities. However, it faces significant challenges from larger competitors and requires robust strategies for brand building and market penetration. Success will depend on its ability to innovate and secure strategic partnerships in a rapidly evolving industry.
Similar Stocks
Sources and Disclaimers
Data Sources:
- General industry reports on digital health market trends.
- Assumptions based on typical company structures in the digital health industry.
Disclaimers:
This analysis is based on publicly available information and general industry knowledge. Specific financial data and detailed operational information for Aimei Health Technology Co., Ltd Right are not readily accessible, which may limit the completeness and accuracy of the assessment. This information is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aimei Health Technology Co., Ltd Right
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2024-01-22 | CEO, Secretary & Director Mr. Junheng Xie | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 
